Cargando…
Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations
Genetic and epigenetic changes in cancer cells are typically divided into “drivers” and “passengers”. Drug development strategies target driver mutations, but inter- and intra-tumoral heterogeneity usually results in emergence of resistance. Here we model intratumoral evolution in the context of a f...
Autores principales: | Gatenby, R A., Cunningham, J. J., Brown, J. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260773/ https://www.ncbi.nlm.nih.gov/pubmed/25407411 http://dx.doi.org/10.1038/ncomms6499 |
Ejemplares similares
-
Distinguishing Driver and Passenger Mutations in an Evolutionary History Categorized by Interference
por: Illingworth, Christopher J. R., et al.
Publicado: (2011) -
Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations
por: Youn, Ahrim, et al.
Publicado: (2013) -
CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome
por: Rogers, Mark F, et al.
Publicado: (2020) -
CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome
por: Rogers, Mark F, et al.
Publicado: (2021) -
Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
por: Shi, Ming-Jun, et al.
Publicado: (2020)